Medicine & TechnologyClinical trials in 12 public and private hospitals in India headed by the University of Bristol and Medanta Institute of Education and Research add evidence to the effectiveness and efficacy of Tocilizumab, a rheumatoid arthritis medication, on severe COVID-19 hospitalized cases.
NHS doctors believe that the 72-year old patient is the first to receive the anti-arthritis drug in UK ahead its large sclae clinical trials on coronavirus patients;he has now recovered and is now at home.